Stryker (SYK) Change in Accured Expenses (2009 - 2026)
Stryker's (SYK) quarterly Change in Accured Expenses came in at -$654.0 million in Q1 2026, down 29.76% year-on-year from -$931.1 million in Q1 2025, and down 265.15% on a QoQ basis from $396.0 million in Q4 2025.
Stryker (SYK) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Accured Expenses data on file, last reported at -$654.0 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 29.76% year-over-year to -$654.0 million in Q1 2026; TTM through Mar 2026 was $168.0 million, a 18.05% decrease from a year earlier, with the FY2025 full-year figure at $318.0 million, up 329.73% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$654.0 million, down from $396.0 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for SYK reached as high as $429.0 million in Q3 2024 and fell as low as -$654.0 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged $24.1 million across 5 years, with a median of $151.0 million in 2022.
- Across the five-year window, Change in Accured Expenses slumped 107.5% in 2024 and soared 2255.56% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $151.0 million in 2022, then soared by 143.05% to $367.0 million in 2023, then retreated by 18.8% to $298.0 million in 2024, then soared by 32.89% to $396.0 million in 2025, then sank by 265.15% to -$654.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$654.0 million in Q1 2026, $396.0 million in Q4 2025, and $38.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -654.00 Mn |
| Mar 31, 2026 | -654.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Dec 31, 2023 | 367.00 Mn |
| Dec 31, 2023 | 367.00 Mn |